biobanks
Biobank Funding & Sustainability -Steps to Success 2015
March 19 by Pharmaceuticals & Biotechnology EditorBiobanks are acknowledged as a necessary and powerful resource for R&D with access to millions of samples and the associated data collected with them, but creating a sustainable framework for bi...
Ensuring Long Term Sample Integrity through Effective Monitoring of Storage Conditions
January 14 by Pharmaceuticals & Biotechnology EditorEnsuring Effective Data Management and Promoting Effective Sample Control In this presentation Peter Jackson, Managing Director, ELPRO UK, discusses why monitoring is required in biobanks, w...
Sample Quality and Integrity: Is Standardisation an Achievable Goal or a Dream?
December 05 by Pharmaceuticals & Biotechnology EditorIn this presentation Dr. Hagen von Briesen, Head of Department, Fraunhofer Institut fuer Biomedizinische Technik (IBMT), shares his insights on: What standards are required and can these standa...
Lesley J Stubbins, Director of Human Biological Sample Management on the Future of Biobanking
December 04 by Pharmaceuticals & Biotechnology EditorIn this interview Lesley J Stubbins, Director of Human Biological Sample Management, Secretariat to Pharmacovigilance Centre of Excellence at GSK, speaks to Andrea Charles from Pharma IQ, about sign...
Keynote Address: NHIR’s BioResource an Alternative to Biobanking
November 26 by Pharmaceuticals & Biotechnology EditorIn this presentation John Bradley, Director, NIHR Biomedical Research Centre, introduces the NIHR BioResource and identifies the initial focus for patient recruitment. Introducing the NI...
Global Biobanking: Industry Overview
August 07 by Pharmaceuticals & Biotechnology EditorPharma IQ in conjunction with the 8th Annual Global Biobanking presents this Global Guide to Biobanking, the definitive resource for professionals in the biobanking area. The guide summarizes the...
Building a Better Biobank- Investing in the Future
April 16 by Pharmaceuticals & Biotechnology EditorThe biobanking landscape is changing rapidly to deal with the increasing demands of the systems biology community. The UK Biobank highlights the continuing advances in the research field with the...
Biorepositories and Biospecimen Research - Science and Standards
August 08 by Andrea CharlesKimberly Myers, Office of Biorepositories and Biospecimen Research, National Cancer Institute, NIH, DHHS, joins Andrea Charles from Pharma IQ, for an update on the progess of the NCI's...
Consent Critical to Building Public Support for Biobanks?
August 04 by Pharma IQEver-increasing demand for personalised medicine has enhanced the global requirement for biobanks to provide human tissue, body fluids and their derivatives. Between the two distinct types of bio...
Existing Research Ethics Protocols Fail in Biobanking Context
July 27 by Pharma IQ NewsIndustry Experts in Sample Management, Ethics Protocols and Biobanking Design to Convene at IQPC Biobanking Conference SAN FRANCISCO, CA - Pharma IQ, a division of IQPC, announces its 5th Biobanking C...
5 Top Tips for Setting up Modern & Effective Global Biobanking Operations
July 15 by Pharma IQBiobanking holds an integral role within the pharmaceutical network, allowing better decisions on early drug development and improved outcomes. As the industry becomes increasingly global, bioban...
Beyond Informed Consent: New Ethics Protocols for Biobanking
June 16 by Amber ScorahIn the context of research involving biobanks, informed consent fails in the two most salient dimensions: in its usual format, informed consent both inhibits important research and yet also fails to...